These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4402291)

  • 1. Maternal modification of responsiveness in the ova-transfer substrain DBA-2eB.
    Uphoff DE
    J Natl Cancer Inst; 1972 May; 48(5):1317-22. PubMed ID: 4402291
    [No Abstract]   [Full Text] [Related]  

  • 2. Maternal modification of antigen recognition in the ova-transfer substrain R3eB.
    Uphoff DE
    J Natl Cancer Inst; 1972 Feb; 48(2):517-22. PubMed ID: 4405705
    [No Abstract]   [Full Text] [Related]  

  • 3. Maternal modification of self-recognition in ova-transfer substrains of C3H mice.
    Uphoff DE
    J Natl Cancer Inst; 1972 Apr; 48(4):965-71. PubMed ID: 4336887
    [No Abstract]   [Full Text] [Related]  

  • 4. Maternal influence on responsiveness of multiparous mice to the antigenic characteristics of their male progeny.
    Uphoff DE
    J Natl Cancer Inst; 1974 Jun; 52(6):1843-7. PubMed ID: 4599649
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors affecting immune responsiveness in vitro of germfree allogeneic radiation chimeras. I. Differences between donor and host strains.
    Beardsley TR; Bealmear PM; Mirand EA; Holtermann OA
    Prog Clin Biol Res; 1983; 132C():433-50. PubMed ID: 6356144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of marrow allograft rejection with radioactive strontium: evidence for marrow-dependent effector cells.
    Bennett M
    J Immunol; 1973 Feb; 110(2):510-6. PubMed ID: 4405320
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of genetically defined nude mice in the study of the mixed leukocyte reaction.
    Croy BA; Osoba D
    J Immunol; 1974 Nov; 113(5):1626-34. PubMed ID: 4278870
    [No Abstract]   [Full Text] [Related]  

  • 8. Maternal modification of tissue antigenicity and the graft-versus-host reaction.
    Uphoff DE
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):84-7. PubMed ID: 4392612
    [No Abstract]   [Full Text] [Related]  

  • 9. Maternal-fetal interactions and histocompatibility antigen polymorphisms.
    Palm J
    Transplant Proc; 1970 Mar; 2(1):162-73. PubMed ID: 4398946
    [No Abstract]   [Full Text] [Related]  

  • 10. [Secondary disease following transplantation of homologous bone marrow to irradiated animals].
    Tumanian MA; Izvekova AV
    Med Radiol (Mosk); 1967 May; 12(5):71-3. PubMed ID: 4392016
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone marrow transplantation incompatibility modified by F 1 graft inocula.
    Chee CA; Ilbery PL; Motta R
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):53-65. PubMed ID: 4402804
    [No Abstract]   [Full Text] [Related]  

  • 12. Two distinct types of late onset graft-versus-host disease after bone marrow transplantation in lethally irradiated mice.
    Heidt PJ; Wagemaker G; Knaan-Shanzer S; van Bekkum DW
    Transplantation; 1981 Sep; 32(3):263-4. PubMed ID: 7025379
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow transplantation across the major histocompatibility barrier in specific-pathogen-free mice: effects of intact versus T cell-depleted bone marrow on the expression of anti-host reaction in the recipient spleens.
    Muto M; Sado T; Aizawa S; Kamisaku H; Kubo E
    J Immunol; 1981 Dec; 127(6):2421-5. PubMed ID: 6457876
    [No Abstract]   [Full Text] [Related]  

  • 14. The transplantation biology of mammalian gestation.
    Billingham RE
    Am J Obstet Gynecol; 1971 Oct; 111(4):469-83. PubMed ID: 4398461
    [No Abstract]   [Full Text] [Related]  

  • 15. Maternal modification of tissue antigenicity and the histocompatibility-2 (H-2) locus.
    Uphoff DE
    J Natl Cancer Inst; 1970 Nov; 45(5):1035-7. PubMed ID: 18605431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the repertoire of T-cell lines and clones specific for minor histocompatibility antigens derived from immunized mice and from mice developing a graft-versus-host reaction.
    Bruley-Rosset M; Miconnet I; Roger T; Seman M; Halle-Pannenko O
    Transplant Proc; 1993 Feb; 25(1 Pt 1):94-5. PubMed ID: 8438503
    [No Abstract]   [Full Text] [Related]  

  • 17. Soluble H-2 antigens: effect on graft-versus-host reaction and factors influencing its effect on host-versus-skin-graft reaction.
    Halle-Pannenko O; Martyre MC; Mathé G
    Transplant Proc; 1972 Dec; 4(4):517-21. PubMed ID: 4405145
    [No Abstract]   [Full Text] [Related]  

  • 18. Graft versus leukemia for "cell cure" of long-passage AKR leukemia after chemoradiotherapy.
    Saltzstein EC; Glasspiegel JS; Rimm AA; Giller RH; Bortin MM
    Cancer Res; 1972 Aug; 32(8):1658-62. PubMed ID: 4402951
    [No Abstract]   [Full Text] [Related]  

  • 19. Maternal control of the immune response.
    Uphoff DE
    Transplant Proc; 1973 Mar; 5(1):197-9. PubMed ID: 4735208
    [No Abstract]   [Full Text] [Related]  

  • 20. Damage of the skin during the acute graft-versus-host reaction in mice.
    Boranić M; Orsanić L; Blazi M
    Transplantation; 1972 Oct; 14(4):442-7. PubMed ID: 4404955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.